We have previously produced nearly 2000 synthetic antagonistic analogues of GHRH [24,26], which have been shown to inhibit, with few adverse effects, the development of 60 human cancer cell lines xenografted into nude mice [26]. The gene discussed is GHRH; the disease is cancer.